Overview
Nimustine has been used in trials studying the treatment of Glioblastoma.
Background
Nimustine has been used in trials studying the treatment of Glioblastoma.
Indication
适用于脑瘤、肺癌、慢性白血病、恶性淋巴瘤、消化道癌。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2016/03/03 | Phase 2 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Nimustine Hydrochloride for Injection | 国药准字H20059251 | 化学药品 | 注射剂 | 7/18/2024 | |
| Nimustine Hydrochloride for Injection | 国药准字H20046672 | 化学药品 | 注射剂 | 6/19/2020 | |
| Nimustine Hydrochloride for Injection | 国药准字H20058694 | 化学药品 | 注射剂 | 3/3/2022 | |
| Nimustine Hydrochloride for Injection | 国药准字H20046533 | 化学药品 | 注射剂 | 7/28/2020 | |
| Nimustine Hydrochloride for Injection | 国药准字H20065314 | 化学药品 | 注射剂(冻干粉针剂) | 1/28/2021 | |
| Nimustine Hydrochloride for Injection | 国药准字H20059604 | 化学药品 | 注射剂 | 9/16/2023 | |
| Nimustine Hydrochloride for Injection | 国药准字H20057157 | 化学药品 | 注射剂 | 7/13/2022 | |
| Nimustine Hydrochloride for Injection | 国药准字H20053686 | 化学药品 | 注射剂 | 8/6/2024 | |
| Nimustine Hydrochloride for Injection | 国药准字H20044292 | 化学药品 | 注射剂 | 5/22/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||